Literature DB >> 28635953

Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians.

Stéphanie Guey1, Markus Kraemer2, Dominique Hervé1,3, Thomas Ludwig4, Manoëlle Kossorotoff5, Françoise Bergametti1, Jan Claudius Schwitalla2, Simone Choi1, Lucile Broseus1, Isabelle Callebaut6, Emmanuelle Genin4, Elisabeth Tournier-Lasserve1,7.   

Abstract

Moyamoya angiopathy (MMA) is a cerebral angiopathy affecting the terminal part of internal carotid arteries. Its prevalence is 10 times higher in Japan and Korea than in Europe. In East Asian countries, moyamoya is strongly associated to the R4810K variant in the RNF213 gene that encodes for a protein containing a RING-finger and two AAA+ domains. This variant has never been detected in Caucasian MMA patients, but several rare RNF213 variants have been reported in Caucasian cases. Using a collapsing test based on exome data from 68 European MMA probands and 573 ethnically matched controls, we showed a significant association between rare missense RNF213 variants and MMA in European patients (odds ratio (OR)=2.24, 95% confidence interval (CI)=(1.19-4.11), P=0.01). Variants specific to cases had higher pathogenicity predictive scores (median of 24.2 in cases versus 9.4 in controls, P=0.029) and preferentially clustered in a C-terminal hotspot encompassing the RING-finger domain of RNF213 (P<10-3). This association was even stronger when restricting the analysis to childhood-onset and familial cases (OR=4.54, 95% CI=(1.80-11.34), P=1.1 × 10-3). All clinically affected relatives who were genotyped were carriers. However, the need for additional factors to develop MMA is strongly suggested by the fact that only 25% of mutation carrier relatives were clinically affected.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28635953      PMCID: PMC5567158          DOI: 10.1038/ejhg.2017.92

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  43 in total

Review 1.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

2.  Genomewide association study identifies no major founder variant in Caucasian moyamoya disease.

Authors:  Wanyang Liu; S T M L D Senevirathna; Toshiaki Hitomi; Hatasu Kobayashi; Constantin Roder; Roman Herzig; Markus Kraemer; Maurits H J Voormolen; Pavlína Cahová; Boris Krischek; Akio Koizumi
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

3.  Atypical presentation of moyamoya disease in an infant with a de novo RNF213 variant.

Authors:  Tamar Harel; Jennifer E Posey; Brett H Graham; Magdalena Walkiewicz; Yaping Yang; Seema R Lalani; John W Belmont
Journal:  Am J Med Genet A       Date:  2015-07-21       Impact factor: 2.802

4.  Identification of a novel RNF213 variant in a family with heterogeneous intracerebral vasculopathy.

Authors:  Katherine R Smith; Richard J Leventer; Mark T Mackay; Kate Pope; Greta Gillies; Martin B Delatycki; David J Amor; Melanie Bahlo; Paul J Lockhart
Journal:  Int J Stroke       Date:  2014-08       Impact factor: 5.266

5.  Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.

Authors:  Takaaki Morimoto; Yohei Mineharu; Hatasu Kobayashi; Kouji H Harada; Takeshi Funaki; Yasushi Takagi; Nobuyuki Sakai; Susumu Miyamoto; Akio Koizumi
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-07-28       Impact factor: 2.136

6.  Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting.

Authors:  Y Mineharu; K Takenaka; H Yamakawa; K Inoue; H Ikeda; K-I Kikuta; Y Takagi; K Nozaki; N Hashimoto; A Koizumi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06-20       Impact factor: 10.154

7.  Endothelial RSPO3 Controls Vascular Stability and Pruning through Non-canonical WNT/Ca(2+)/NFAT Signaling.

Authors:  Beate Scholz; Claudia Korn; Jessica Wojtarowicz; Carolin Mogler; Iris Augustin; Michael Boutros; Christof Niehrs; Hellmut G Augustin
Journal:  Dev Cell       Date:  2016-01-11       Impact factor: 12.270

8.  Genetic variant RNF213 c.14576G>A in various phenotypes of intracranial major artery stenosis/occlusion.

Authors:  Satoru Miyawaki; Hideaki Imai; Masahiro Shimizu; Shinichi Yagi; Hideaki Ono; Akitake Mukasa; Hirofumi Nakatomi; Tsuneo Shimizu; Nobuhito Saito
Journal:  Stroke       Date:  2013-08-22       Impact factor: 7.914

9.  The Phyre2 web portal for protein modeling, prediction and analysis.

Authors:  Lawrence A Kelley; Stefans Mezulis; Christopher M Yates; Mark N Wass; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2015-05-07       Impact factor: 13.491

10.  Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing.

Authors:  Lorelei D Shoemaker; Michael J Clark; Anil Patwardhan; Gemma Chandratillake; Sarah Garcia; Rong Chen; Alexander A Morgan; Nan Leng; Scott Kirk; Richard Chen; Douglas J Cook; Michael Snyder; Gary K Steinberg
Journal:  G3 (Bethesda)       Date:  2015-11-03       Impact factor: 3.542

View more
  24 in total

1.  Moyamoya angiopathy in PHACE syndrome not associated with RNF213 variants.

Authors:  Jeffrie Hadisurya; Stephanie Guey; Lou Grangeon; Dagmar Wieczorek; Michaelle Corpechot; Jan Claudius Schwitalla; Markus Kraemer
Journal:  Childs Nerv Syst       Date:  2019-04-29       Impact factor: 1.475

2.  Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patients.

Authors:  Markus Kraemer; Jan Claudius Schwitalla; Frank Diesner; Orhan Aktas; Hans-Peter Hartung; Peter Berlit
Journal:  J Neurol       Date:  2019-03-13       Impact factor: 4.849

3.  Extension of SKAT to multi-category phenotypes through a geometrical interpretation.

Authors:  Emmanuelle Génin; Hervé Perdry; Ozvan Bocher; Gaelle Marenne; Elisabeth Tournier-Lasserve
Journal:  Eur J Hum Genet       Date:  2021-01-14       Impact factor: 5.351

Review 4.  Juvenile Moyamoya and Craniosynostosis in a Child with Deletion 1p32p31: Expanding the Clinical Spectrum of 1p32p31 Deletion Syndrome and a Review of the Literature.

Authors:  Paolo Prontera; Daniela Rogaia; Amedea Mencarelli; Valentina Ottaviani; Ester Sallicandro; Giorgio Guercini; Susanna Esposito; Anna Bersano; Giuseppe Merla; Gabriela Stangoni
Journal:  Int J Mol Sci       Date:  2017-09-17       Impact factor: 5.923

5.  Microduplication of 15q13.3 and Microdeletion of 18q21.32 in a Patient with Moyamoya Syndrome.

Authors:  Sciacca Francesca Luisa; Ambra Rizzo; Gloria Bedini; Fioravante Capone; Vincenzo Di Lazzaro; Sara Nava; Francesco Acerbi; Davide Sebastiano Rossi; Simona Binelli; Giuseppe Faragò; Andrea Gioppo; Marina Grisoli; Maria Grazia Bruzzone; Paolo Ferroli; Chiara Pantaleoni; Luigi Caputi; Jesus Vela Gomez; Eugenio Agostino Parati; Anna Bersano
Journal:  Int J Mol Sci       Date:  2018-11-20       Impact factor: 5.923

6.  Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1.

Authors:  Claudia Santoro; Teresa Giugliano; Markus Kraemer; Annalaura Torella; Jan Claudius Schwitalla; Mario Cirillo; Daniela Melis; Peter Berlit; Vincenzo Nigro; Silverio Perrotta; Giulio Piluso
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

7.  Association of De Novo RNF213 Variants With Childhood Onset Moyamoya Disease and Diffuse Occlusive Vasculopathy.

Authors:  Amélie Pinard; Maximillian D J Fiander; Alana C Cecchi; Andrea L Rideout; Mohamed Azouz; Stuart M Fraser; P Daniel McNeely; Simon Walling; Sarah C Novara; Anna C E Hurst; Dongchuan Guo; Sandhya Parkash; Michael J Bamshad; Deborah A Nickerson; Anthony M Vandersteen; Dianna M Milewicz
Journal:  Neurology       Date:  2021-02-10       Impact factor: 9.910

8.  A new syndrome of moyamoya disease, kidney dysplasia, aminotransferase elevation, and skin disease associated with de novo variants in RNF213.

Authors:  Alanna Strong; Gina O'Grady; Evelyn Shih; Jonathan R Bishop; Kathleen Loomes; Tamir Diamond; Erum A Hartung; William Wong; Sanmati Cuddapah; Anne Marie Cahill; Cuiping Hou; Diana Slater; Courtney Vaccaro; Deborah Watson; Dong Li; Hakon Hakonarson
Journal:  Am J Med Genet A       Date:  2021-05-07       Impact factor: 2.802

9.  PHACTR1 is associated with disease progression in Chinese Moyamoya disease.

Authors:  Yongbo Yang; Jian Wang; Qun Liang; Yi Wang; Xinhua Chen; Qingrong Zhang; Shijie Na; Yi Liu; Ting Yan; Chunhua Hang; Yichao Zhu
Journal:  PeerJ       Date:  2020-05-05       Impact factor: 2.984

10.  Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells.

Authors:  Francesca Tinelli; Sara Nava; Francesco Arioli; Gloria Bedini; Emma Scelzo; Daniela Lisini; Giuseppe Faragò; Andrea Gioppo; Elisa F Ciceri; Francesco Acerbi; Paolo Ferroli; Ignazio G Vetrano; Silvia Esposito; Veronica Saletti; Chiara Pantaleoni; Federica Zibordi; Nardo Nardocci; Maria Luisa Zedde; Alessandro Pezzini; Vincenzo Di Lazzaro; Fioravante Capone; Maria Luisa Dell'Acqua; Peter Vajkoczy; Elisabeth Tournier-Lasserve; Eugenio A Parati; Anna Bersano; Laura Gatti
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.